Inventor · disambiguated record
Susheel Jethanand Nara
Also filed as: NARA SUSHEEL JETHANAND
28 granted patents·3 pending applications·48 citations·filing 2013–2021
94Inventor score
Top patents by PatentIndex Score
31 records- 0194US9790169B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 17, 2017·19 cites·27 claims
- 0291US11713312B2Substituted bicyclic compounds as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Aug 1, 2023·2 cites·14 claims
- 0388US11254663B2Substituted bicyclic compounds as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 22, 2022·2 cites·26 claims
- 0488US10959986B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 30, 2021·3 cites·42 claims
- 0583US10399933B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 0682US10399932B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 0780US11253525B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 22, 2022·1 cites·32 claims
- 0879US10544120B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·2 cites·3 claims
- 0976US12145927B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 19, 2024·1 cites·11 claims
- 1076US10253027B2Aryl lactam kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 9, 2019·3 cites·6 claims
- 1176US9708337B2Aryl amide-based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 18, 2017·3 cites·10 claims
- 1275US10167254B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·1 cites·43 claims
- 1374US11337970B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 24, 2022·1 cites·5 claims
- 1471US10246469B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 2, 2019·1 cites·8 claims
- 1569US8703953B2Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 22, 2014·1 cites·8 claims
- 1667US8901305B2Aryl lactam kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 2, 2014·1 cites·11 claims
- 1765US9932320B2Quinoline-based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 3, 2018·1 cites·10 claims
- 1856US12275720B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB·Filed 2021·Granted Apr 15, 2025·0 cites·13 claims
- 1953US12286424B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB CO·Filed 2021·Granted Apr 29, 2025·0 cites·19 claims
- 2053US12269819B2Small molecule inhibitors of Galectin-3BRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 8, 2025·0 cites·13 claims
- 2153US8969564B2Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 3, 2015·0 cites·3 claims
- 2249US12319676B2Substituted amide compounds useful as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 3, 2025·0 cites·13 claims
- 2349US12059420B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 13, 2024·0 cites·6 claims
- 2446US12227496B2Substituted bicyclic compounds as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 18, 2025·0 cites·11 claims
- 2546US12030835B2Substituted amide compounds useful as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jul 9, 2024·0 cites·15 claims
- 2643US2016222021A1Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2743US2016333006A1Aryl lacta kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2842US10730863B2Bridged bicyclic compounds as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 4, 2020·0 cites·27 claims
- 2937US10174044B2Fused pyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 8, 2019·0 cites·12 claims
- 3035US10035777B2Heterocyclic kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 31, 2018·0 cites·12 claims
- 3135US2017239249A1Quinazoline-based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Susheel Jethanand Nara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →